approval · primary record
BENRALIZUMAB
FDA · BLA · 2026-05-13
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-13 |
| Brand | FASENRA |
| Sponsor | ASTRAZENECA AB |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:59.829Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BENRALIZUMAB:2026-05-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Benralizumab · trial
- Benralizumab · compound